A case–control study confirms that levels of P‐S96‐tau, P‐T181‐tau, and Aβ1‐42 in neurogenic blood exosomal extracts predict the onset of AD up to 10 years prior to the clinical onset of the disease.206. The gene discussed is MAPT; the disease is Alzheimer disease.